Stay updated on pIL-12/MK-3475 Combo for Melanoma Clinical Trial
Sign up to get notified when there's something new on the pIL-12/MK-3475 Combo for Melanoma Clinical Trial page.

Latest updates to the pIL-12/MK-3475 Combo for Melanoma Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has been updated to reflect a new version (v2.15.0) and includes the addition of collaborators OncoSec Medical Incorporated and Merck Sharp & Dohme LLC, while significant details about the trial's methodology and patient criteria have been removed.SummaryDifference44%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check87 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to pIL-12/MK-3475 Combo for Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the pIL-12/MK-3475 Combo for Melanoma Clinical Trial page.